Author | John M. Burke, MD | OncLive

Author | John M. Burke, MD

Articles

Dr. Burke on Treatment Options in Low-Tumor Burden Follicular Lymphoma

September 16, 2020

John M. Burke, MD, discusses treatment options for patients with early-stage or advanced follicular lymphoma with a low tumor burden.

Dr. Burke on Tazemetostat’s Mechanism of Action in EZH2-Mutated Follicular Lymphoma

August 22, 2020

John M. Burke, MD, discusses the role of tazemetostat in EZH2-mutated follicular lymphoma.

Dr. Burke on Current FDA Indications for BTK Inhibitors in B-Cell Malignancies

July 20, 2020

John M. Burke, MD, discusses current indications for BTK inhibitors in B-cell malignancies.

Dr. Burke on Research With Tafasitamab in Lymphoma

May 09, 2020

John M. Burke, MD, discusses research with tafasitamab (MOR208) in lymphoma.

x